Skip to main content
SpringerLink
Log in

Biological properties of VEGF/VPF receptors

  • Tumor Angiogenesis
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gospodarowicz D, Abraham FA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311–7315, 1989

    Google Scholar 

  2. Shweiki D, Itin A, Soffer D Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845, 1992

    Google Scholar 

  3. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk1 mutant. Nature 367: 576–579, 1994

    Google Scholar 

  4. Kim J, Li B, Winer J, Armaninum M, Gillet N, Phiips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 262: 841–844, 1993

    Google Scholar 

  5. Terman BI, Carrion ME, Kovacs E, Rasmussen R, Eddy RL, Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677–1683, 1991

    Google Scholar 

  6. Terman BI, Dougher-Vermanzen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Com 187: 1579–1586, 1992

    Google Scholar 

  7. Mattews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR, A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88: 9026–9030, 1991

    Google Scholar 

  8. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835–846, 1993

    Google Scholar 

  9. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519–524, 1990

    Google Scholar 

  10. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989–991, 1992

    Google Scholar 

  11. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Ann Rev Biochem 62: 453–481, 1993

    Google Scholar 

  12. Pajusola K, Aprlikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52: 5738–5743, 1992

    Google Scholar 

  13. Galland F, Karamysheva A, Pebusque M-J, Borg J-P, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D: The FL4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor. Oncogene 8: 1233–1240, 1993

    Google Scholar 

  14. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309–1312, 1989

    Google Scholar 

  15. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306–1309, 1989

    Google Scholar 

  16. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA: Amino acid and cDNA sequence of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87: 2628–2632, 1990

    Google Scholar 

  17. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267–9271, 1991

    Google Scholar 

  18. Kendall RL, Wang G, DiSalvo J, Thomas KA: Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 201: 326–330, 1994

    Google Scholar 

  19. Park JE, Chen HH, Winer J, Houck KA, Farrara N: Placenta growth factor. J Biol Chem 269: 25646–25654, 1994

    Google Scholar 

  20. Terman BI, Khandke L, Dougher-Vermazon M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M: VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11: 187–195, 1994

    Google Scholar 

  21. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA: Purification and characterization of a naturally occurring vascular growth factor/placenta growth factor heterodimer. J Biol Chem 270: 7717–7723, 1995

    Google Scholar 

  22. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld: The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267: 6093–6098, 1992

    Google Scholar 

  23. Tessler S, Rockwell P, Hicklin D, Cohen T, Levi B-Z, Witte L, Lemischka IR, Neufeld G: Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269: 12456–12461, 1994

    Google Scholar 

  24. Kaplan J, Dougher-Vermazen M, Terman BI: Manuscript in preparation

  25. Ornitz D, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12: 240–247, 1992

    Google Scholar 

  26. Kan M, Wang F, Xu F, Crabb JW, Hou J, Mckeehan WL: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259: 1918–1921, 1993

    Google Scholar 

  27. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 58: 575–606, 1989

    Google Scholar 

  28. Soker S, Goldstaub D, Svahn CM, Vlodavsky I, Levi B-Z, Neufeld G. Variations in the size of sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. Biochem Biophys Res Commun 203: 1339–1347, 1994

    Google Scholar 

  29. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi B-Z, Neufeld G: VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322–11326, 1995

    Google Scholar 

  30. Klagsbrun M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229–231, 1991

    Google Scholar 

  31. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. J Biol Chem 266: 11947–11954, 1991

    Google Scholar 

  32. Houck KA, Farrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806–1814, 1991

    Google Scholar 

  33. Waltenberger J, Claesson-Welsh L, Siegnahn A, Shibuya S, Heldin C-H: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988–26995, 1994

    Google Scholar 

  34. Dougher-Vermazen M, Holmes J, Bohlen P, Terman BI: Biological activity of autophosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF receptor. Biochem Biophys Res Commun 205: 728–738, 1994

    Google Scholar 

  35. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10: 135–147, 1995

    Google Scholar 

  36. Cunningham SA, Waxham MN, Arrate PM, Brock TA: Interaction of the FLT-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 270: 20254–20257, 1995

    Google Scholar 

  37. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964–3968, 1995

    Google Scholar 

  38. Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358–1364, 1995

    Google Scholar 

  39. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845–848, 1992

    Google Scholar 

  40. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789–1797, 1995

    Google Scholar 

  41. Peters KG, De Vries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915–8919, 1993

    Google Scholar 

  42. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van De Water L: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunology 22: 2801–2807, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wyeth-Ayerst Oncology Research, 10965, Pearl River, NY, USA

    Bruce I. Terman & Maureen Dougher-Vermazen

Authors
  1. Bruce I. Terman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maureen Dougher-Vermazen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terman, B.I., Dougher-Vermazen, M. Biological properties of VEGF/VPF receptors. Cancer Metast Rev 15, 159–163 (1996). https://doi.org/10.1007/BF00437468

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00437468

Key words

Search

Navigation